MarketPulse

companion diagnostic

2 articles
BenzingaBenzinga··Vandana Singh

Pfizer, Arvinas Secure FDA Approval for Groundbreaking PROTAC Breast Cancer Drug

FDA approves VEPPANU, first PROTAC therapy for advanced breast cancer with ESR1 mutations, showing 43% reduction in disease progression risk versus existing treatment.
PFEARVNGHFDA approvalbreast cancer
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Allarity Therapeutics Secures $20M Funding to Accelerate Stenoparib FDA Path

Allarity Therapeutics secures $20M non-dilutive debt financing to complete stenoparib Phase 2 trial and advance toward FDA approval, extending runway to mid-2028.
ALLRFDA approvaldebt financing